-
Correspondence
-
- Correspondence on editorial regarding “Atezolizumab and bevacizumab for hepatocellular carcinoma: how to approach salvage therapy for non-responders?”
-
Young Eun Chon1, Dong Yun Kim2, Hong Jae Chon3, Do Young Kim2
-
1Department of Gastroenterology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea
2Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
3Department of Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea
- Corresponding author: Hong Jae Chon ,Tel: +82-31-780-5210, Email: minidoctor@cha.ac.kr
Do Young Kim ,Tel: 82-2-2228-1930, Fax: 82-2-393-1395, Email: dyk1025@yuhs.ac
- Received: May 24, 2024; Accepted: May 29, 2024.
